IMMUNOGEN, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Item 7.01 Regulation FD Disclosure. On January 4, 2023, ImmunoGen, Inc. issued a press release announcing the appointment of Michael J. Vasconcelles, M.D. as Executive Vice President, Research,... | January 4, 2023
Source: marketscreener.com